Multimodal Imaging Analysis of Tissue Changes Occurring During Treatment With Antiangiogenic (Bevacizumab) in Patients With Recurrent Glioblastoma
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Bevacizumab (Primary)
- Indications Glioblastoma
- Focus Diagnostic use
- Acronyms IMAGLIO
- 22 Dec 2016 New trial record